BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Wang WP, Shi D, Yun D, Hu J, Wang JF, Liu J, Yang YP, Li MR, Wang JF, Kong DL. Role of deubiquitinase JOSD2 in the pathogenesis of esophageal squamous cell carcinoma. World J Gastroenterol 2024; 30(6): 565-578 [PMID: 38463028 DOI: 10.3748/wjg.v30.i6.565]
URL: https://www.wjgnet.com/1007-9327/full/v30/i6/565.htm
Number Citing Articles
1
Ming Hou, Hanbing Jia, Chongyang Liu, Cheng Wang. Molecular mechanism of bisphenol A in promoting esophageal carcinoma based on network toxicology and molecular dockingMedicine 2025; 104(52): e46829 doi: 10.1097/MD.0000000000046829
2
阳伊娜 欧. The Potential Role of Deubiquitinating Enzyme OTUB1 in Sorafenib Resistance of Hepatocellular Carcinoma and Screening of Targeting CompoundsPharmacy Information 2025; 14(05): 357 doi: 10.12677/pi.2025.145041
3
Sara Polo-Alonso, Álvaro Hernáez, Irene Dégano, Ruth Martí-Lluch, Mel·lina Pinsach-Abuin, Roberto Elosua, Isaac Subirana, Marta Puigmulé, Alexandra Pérez, Raquel Cruz, Silvia Diz-de Almeida, Eulàlia Puigdecanet, Elisabet Selga, Xavier Nogues, Joan Masclans, Roberto Güerri-Fernández, Héctor Cubero-Gallego, Helena Tizon-Marcos, Beatriz Vaquerizo, Ramon Brugada, Rafel Ramos, Anna Camps-Vilaró, Jaume Marrugat. Global and Sex-Stratified Genome-Wide Association Study of Long COVID Based on Patient-Driven Symptom RecallInternational Journal of Molecular Sciences 2025; 26(18): 9252 doi: 10.3390/ijms26189252
4
Yali Xian, Jing Ye, Yu Tang, Nan Zhang, Cheng Peng, Wei Huang, Gu He. Deubiquitinases as novel therapeutic targets for diseasesMedComm 2024; 5(12) doi: 10.1002/mco2.70036
5
Xiusen Zhang, Xudong Zhang, Xing Jin, Shilei Zhang, Xin Zhao, Hairui Wang, Hui Wang, Lijun Deng, Wenchao Tang, Qizhi Fu, Shegan Gao. Atlas-Guided Nanocarrier Strategies Targeting Spatial NTRK2/MAPK Signaling in EGFR-TKI-Resistant Niches of Esophageal Squamous Cell CarcinomaPharmaceutics 2026; 18(2): 181 doi: 10.3390/pharmaceutics18020181